Edgewise Therapeutics, Inc. EWTX Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s accrued manufacturing costs?
- Edgewise Therapeutics, Inc. (EWTX) reported accrued manufacturing costs of $5.68M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s accrued manufacturing costs changed year-over-year?
- Edgewise Therapeutics, Inc.'s accrued manufacturing costs increased by 42.9% year-over-year, from $3.97M to $5.68M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s accrued manufacturing costs has grown at a 60.3% compound annual growth rate (CAGR), from $1.18M to $12.43M.